Qualigen Therapeutics Statistics

Total Valuation

AIXC has a market cap or net worth of $4.82 million. The enterprise value is -$30.10 million.

Market Cap	4.82M
Enterprise Value	-30.10M

Important Dates

The next estimated earnings date is Friday, November 21, 2025.

Earnings Date	Nov 21, 2025
Ex-Dividend Date	n/a

Share Statistics

AIXC has 1.70 million shares outstanding. The number of shares has increased by 654.38% in one year.

Current Share Class	1.70M
Shares Outstanding	1.70M
Shares Change (YoY)	+654.38%
Shares Change (QoQ)	-63.14%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	2.26%
Float	1.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.01
P/TBV Ratio	2.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.83, with a Debt / Equity ratio of 0.08.

Current Ratio	8.83
Quick Ratio	7.88
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9.39

Financial Efficiency

Return on equity (ROE) is -39.69% and return on invested capital (ROIC) is -21.03%.

Return on Equity (ROE)	-39.69%
Return on Assets (ROA)	-18.87%
Return on Invested Capital (ROIC)	-21.03%
Return on Capital Employed (ROCE)	-17.93%
Revenue Per Employee	n/a
Profits Per Employee	-$2.02M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, AIXC has paid $5,569 in taxes.

Income Tax	5,569
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.25% in the last 52 weeks. The beta is 0.28, so AIXC's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	-22.25%
50-Day Moving Average	3.58
200-Day Moving Average	3.23
Relative Strength Index (RSI)	45.66
Average Volume (20 Days)	3,511,835

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-24,681
Operating Income	-6.91M
Pretax Income	-7.22M
Net Income	-8.09M
EBITDA	n/a
EBIT	-6.91M
Earnings Per Share (EPS)	-$5.61

Full Income Statement

Balance Sheet

The company has $38.78 million in cash and $3.24 million in debt, giving a net cash position of $35.54 million or $20.96 per share.

Cash & Cash Equivalents	38.78M
Total Debt	3.24M
Net Cash	35.54M
Net Cash Per Share	$20.96
Equity (Book Value)	38.55M
Book Value Per Share	0.80
Working Capital	38.55M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-7.10M
Capital Expenditures	n/a
Free Cash Flow	-7.10M
FCF Per Share	-$4.19

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AIXC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-654.38%
Shareholder Yield	-654.38%
Earnings Yield	-148.73%
FCF Yield	-130.43%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 5, 2024. It was a reverse split with a ratio of 1:50.

Last Split Date	Nov 5, 2024
Split Type	Reverse
Split Ratio	1:50

Scores

Altman Z-Score	n/a
Piotroski F-Score	2